SOURCE: Brighton Markets

June 08, 2012 09:00 ET

Calendar of Events - Report Highlights Valeant Pharmaceuticals Int (USA) and Zimmer Holdings, Inc.

HONG KONG--(Marketwire - Jun 8, 2012) - Today, www.BrightonMarkets.com announced new reports highlighting Valeant Pharmaceuticals Int (USA) (NYSE: VRX) and Zimmer Holdings, Inc. (NYSE: ZMH). Gain market insight with full analysis and research downloads available at www.BrightonMarkets.com/index.php?coa=VRX&cob=ZMH.

With markets in correction mode, investors are looking to quantify an accurate model, weighing positives and negatives of the months ahead. Upcoming negative pressures include China's slowdown, the European recession, the end of the Fed's Operation Twist stimulus program, continued geopolitical risks, election uncertainty, and potential 2013 budget bombshell of tax hikes and spending cuts. Meanwhile, positive offsets are driven by central banks (particularly China) cutting rather than hiking rates, deceleration in fuel and food prices, increase in consumer sentiment and resulting retail sales, signs of improvement in housing sales and new strength in auto production schedules.

Despite the current situation, our team continues to identify high momentum situations with growth potential -- there remains strong opportunity within careful discretion.

Brighton Markets is releasing new coverage on Valeant Pharmaceuticals Int (USA) for its current position within the healthcare industry. Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. It operates in five business segments: U.S. Neurology and Other, U.S. Dermatology, Canada and Australia, Branded Generics - Europe and Branded Generics -Latin America. The full research report on Valeant Pharmaceuticals Int (USA) (NYSE: VRX) is available here: www.BrightonMarkets.com/index.php?coa=VRX.

Brighton Markets has released research on Zimmer Holdings, Inc. for its changing role within the healthcare industry. Zimmer Holdings, Inc. (Zimmer) designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, biologics, dental implants and related surgical products. The full research report on Zimmer Holdings, Inc. (NYSE: ZMH) is available here: www.BrightonMarkets.com/index.php?cob=ZMH.

About Brighton Markets
Brighton Markets was founded on the guiding principle of providing highly relevant, meaningful, and actionable information direct to investors. Across the investment spectrum, Brighton Markets shines light on today's events.

Contact Information